EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:6950 - mirtazapine
| Formula | C17H19N3 |
| Net Charge | 0 |
| Average Mass | 265.360 |
| Monoisotopic Mass | 265.15790 |
| SMILES | CN1CCN2c3ncccc3Cc3ccccc3C2C1 |
| InChI | InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3 |
| InChIKey | RONZAEMNMFQXRA-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | alpha-adrenergic antagonist An agent that binds to but does not activate α-adrenergic receptors thereby blocking the actions of endogenous or exogenous α-adrenergic agonists. α-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. histamine antagonist Histamine antagonists are the drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. serotonergic antagonist Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists. H1-receptor antagonist H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. |
| Applications: | alpha-adrenergic antagonist An agent that binds to but does not activate α-adrenergic receptors thereby blocking the actions of endogenous or exogenous α-adrenergic agonists. α-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. histamine antagonist Histamine antagonists are the drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. serotonergic antagonist Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists. H1-receptor antagonist H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. oneirogen Any substance that produces or enhances dream-like states of consciousness. anxiolytic drug Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| mirtazapine (CHEBI:6950) has role anxiolytic drug (CHEBI:35474) |
| mirtazapine (CHEBI:6950) has role H1-receptor antagonist (CHEBI:37955) |
| mirtazapine (CHEBI:6950) has role histamine antagonist (CHEBI:37956) |
| mirtazapine (CHEBI:6950) has role oneirogen (CHEBI:146270) |
| mirtazapine (CHEBI:6950) has role serotonergic antagonist (CHEBI:48279) |
| mirtazapine (CHEBI:6950) has role α-adrenergic antagonist (CHEBI:37890) |
| mirtazapine (CHEBI:6950) is a benzazepine (CHEBI:35676) |
| mirtazapine (CHEBI:6950) is a tetracyclic antidepressant (CHEBI:50940) |
| IUPAC Name |
|---|
| 2-methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine |
| INNs | Source |
|---|---|
| mirtazapina | ChEBI |
| mirtazapine | ChEBI |
| mirtazapinum | ChEBI |
| Synonyms | Source |
|---|---|
| 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine | ChemIDplus |
| Mirtazapine | KEGG COMPOUND |
| Registry Numbers | Sources |
|---|---|
| Beilstein:549345 | Beilstein |
| CAS:61337-67-5 | ChemIDplus |
| Citations |
|---|